Assessing the Clinical Utility of Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer

American Society of Clinical Oncology, Journal of Clinical Oncology, 6(41), p. 1323-1323, 2023

Journal article published in 2023 by Zachary R. McCaw

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by